对比结直肠癌患者采用检验粪便及肿瘤标志物的检验方法区别

Value of Stool and Tumor Markers in Diagnosis and Treatment of Colorectal Cancer

目的对结直肠癌进行诊治时采取粪便以及肿瘤标志物检验方法,分析其应用效果。方法选取2017年1月至2018年12月在齐齐哈尔市第一医院接受检验的60例结直肠癌患者,分别对这些患者实施粪便检验以及肿瘤标志物检验,在对其实施病理学检验,对比这两种检验方法和病理学检验的差别。结果粪便检验联合肿瘤标志物检验和病理性活检结果对比(P>0.05)。结论针对结直肠癌患者可以通过应用粪便检验以及肿瘤标志物检验的方法来了解患者机体状况,有利于为后期治疗提供可靠的依据。

Objective To analyze the aggravation of the application of stool and tumor markers in the diagnosis and treatment of colorectal cancer.Methods A total of 60 patients with colorectal cancer were selected in this study.They were all examined in our hospital from January 2017 to December 2018.Fecal examination and tumor marker test were performed on these patients respectively.Pathological examination was performed on these patients,and the differences between the two methods and pathological examination were compared.Results The results of stool test combined with tumor marker test and pathological biopsy were compared(P>0.05).Conclusion For patients with colorectal cancer,we can use stool test and tumor marker test to understand the patient's body condition,which is conducive to providing a reliable basis for later treatment.